Redox-proteomics of the effects of homogentisic acid in an in vitro human serum model of alkaptonuric ochronosis

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Inherited Metabolic Disease

• Publication date

  2011-08-27

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1007/s10545-011-9377-6PMID 21874298
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evaluation of anti-oxidant treatments in an in vitro model of alkaptonuric ochronosis.

  2010cited by this paper
• N‐acetylcysteine prevents nitric oxide‐induced chondrocyte apoptosis and cartilage degeneration in an experimental model of osteoarthritis

  2010cited by this paper
• Proteomic and redox‐proteomic evaluation of homogentisic acid and ascorbic acid effects on human articular chondrocytes

  2010cited by this paper
• Aboard transthyretin: From transport to cleavage

  2010cited by this paper
• Evaluation of antioxiodant drugs for the treatment of ochronotic alkaptonuria in an in vitro human cell model

  2010cited by this paper
• Alpha Lipoic Acid Alleviates Oxidative Stress and Preserves Blood Brain Permeability in Rats with Subarachnoid Hemorrhage

  2010cited by this paper
• Lipoic acid effects on lipid peroxidation level, superoxide dismutase activity and monoamines concentration in rat hippocampus.

  2009cited by this paper
• Molecular Mechanisms and Potential Clinical Significance of S-Glutathionylation

  2008cited by this paper
• Neuroprotective effect of the natural iron chelator, phytic acid in a cell culture model of Parkinson's disease.

  2008cited by this paper
• Depletion of thiol‐containing proteins in response to quinones in Bacillus subtilis

  2008cited by this paper
• Cysteinylation and homocysteinylation of plasma protein thiols during ageing of healthy human beings

  2008influential reference
• Alkaptonuria – a review of surgical and autopsy pathology

  2008cited by this paper
• American Journal of Physiology- Lung Cellular and Molecular Physiology publishes original research covering

  2007cited by this paper
• Determination of plasma thiol bound to albumin using affinity chromatography and high-performance liquid chromatography with fluorescence detection: ratio of cysteinyl albumin as a possible biomarker of oxidative stress.

  2007cited by this paper
• Cytochrome P450 destruction by benzene metabolites 1,4-benzoquinone and 1,4-hydroquinone and the formation of hydroxyl radicals in minipig liver microsomes.

  2007cited by this paper
• Control of extracellular cysteine/cystine redox state by HT-29 cells is independent of cellular glutathione.

  2007cited by this paper
• S-glutathionylation in protein redox regulation.

  2007cited by this paper
• Impact of diabetes mellitus on the relationships between iron‐, inflammatory‐ and oxidative stress status

  2006cited by this paper
• Attenuation of tamoxifen-induced hepatotoxicity by taurine in mice.

  2006cited by this paper
• Enhancement of DMNQ-induced hepatocyte toxicity by cytochrome P450 inhibition.

  2006cited by this paper
• Alpha-lipoic acid suppresses the development of collagen-induced arthritis and protects against bone destruction in mice

  2006cited by this paper
• Redefining Oxidative Stress

  2006cited by this paper
• Effect of quinones on microtubule polymerization: a link between oxidative stress and cytoskeletal alterations in Alzheimer's disease.

  2005cited by this paper
• Effects of N-Acetylcysteine, Quercetin, and Phytic Acid on Spontaneous Hepatic and Renal Lesions in LEC Rats

  2005cited by this paper
• Cysteine modification by lipid peroxidation products inhibits protein disulfide isomerase.

  2005cited by this paper
• The extraordinary ligand binding properties of human serum albumin

  2005cited by this paper
• New developments in ochronosis: review of the literature

  2005cited by this paper
• Plasma albumin cysteinylation is regulated by cystathionine β-synthase

  2004cited by this paper
• Alkaptonuria, ochronosis, and ochronotic arthropathy.

  2004cited by this paper
• Oxidation in rheumatoid arthritis

  2004cited by this paper
• Plasma albumin cysteinylation is regulated by cystathionine beta-synthase.

  2004cited by this paper
• Quinones and glutathione metabolism.

  2004cited by this paper
• Protein targets of 1,4‐benzoquinone and 1,4‐naphthoquinone in human bronchial epithelial cells

  2003cited by this paper
• Alkaptonuria.

  2003cited by this paper
• Community-acquired pneumonia [5] (multiple letters)

  2003cited by this paper
• Natural history of alkaptonuria.

  2002influential reference
• The role of cysteine residues in the oxidation of ferritin.

  2002cited by this paper
• Covalent modification of amino acid nucleophiles by the lipid peroxidation products 4-hydroxy-2-nonenal and 4-oxo-2-nonenal.

  2002cited by this paper
• Sulfur in human nutrition and applications in medicine.

  2002cited by this paper
• Outcome of tyrosinaemia type III

  2001cited by this paper
• Modification of ferritin during iron loading.

  2001cited by this paper
• Protein Damage and Degradation by Oxygen Radicals

  2001cited by this paper
• Identification of proteins containing cysteine residues that are sensitive to oxidation by hydrogen peroxide at neutral pH.

  2000influential reference
• Chronic ochronotic arthritis: clinical, arthroscopic, and pathologic findings.

  2000cited by this paper
• Oscillatory oxido-reductive reaction of intracellular hemoglobin in human erythrocyte incubated with o-aminophenol.

  2000cited by this paper
• Adaptation of protein carbonyl detection to the requirements of proteome analysis demonstrated for hypoxia/reoxygenation in isolated rat liver mitochondria.

  2000cited by this paper
• Depletion of cellular protein thiols as an indicator of arylation in isolated trout hepatocytes exposed to 1,4-benzoquinone.

  2000cited by this paper
• Total antioxidant capacity as a tool to assess redox status: critical view and experimental data.

  2000cited by this paper
• Multi-effective properties of homogentisic acid revealed in reactions with human hemoglobin and human erythrocytic hemoglobin.

  2000cited by this paper
• Extensive Bluish Gray Skin Pigmentation and Severe Arthropathy

  2000cited by this paper
• Extensive bluish gray skin pigmentation and severe arthropathy. Endogenous ochronosis (alkaptonuria).

  2000cited by this paper
• Characterization of a nonsense mutation in the ceruloplasmin gene resulting in diabetes and neurodegenerative disease.

  1996cited by this paper
• Hereditary ceruloplasmin deficiency with hemosiderosis

  1996cited by this paper
• The molecular basis of alkaptonuria

  1996cited by this paper
• Aceruloplasminemia: molecular characterization of this disorder of iron metabolism.

  1995cited by this paper
• Quinoproteins

  1994cited by this paper
• Homogentisic acid and structurally related compounds as intermediates in plasma soluble melanin formation and in tissue toxicities.

  1994cited by this paper
• Measurement of protein thiol groups and glutathione in plasma.

  1994influential reference
• Apolipoprotein AI mutation Arg-60 causes autosomal dominant amyloidosis.

  1992cited by this paper
• Stoichiometry of Fe(II) oxidation during ceruloplasmin-catalyzed loading of ferritin.

  1992cited by this paper
• Specific detection of quinoproteins by redox-cycling staining.

  1991influential reference
• A mutation in apolipoprotein A-I in the Iowa type of familial amyloidotic polyneuropathy.

  1990cited by this paper
• Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal.

  1990cited by this paper
• Modulation of cellular glutathione and protein thiol status during quinone metabolism.

  1990cited by this paper
• Increased carbonyl content of proteins in synovial fluid from patients with rheumatoid arthritis.

  1989cited by this paper
• Chondrocyte growth inhibition induced by homogentisic acid and its partial prevention with ascorbic acid.

  1989influential reference
• Variant apolipoprotein AI as a major constituent of a human hereditary amyloid.

  1988cited by this paper
• Homogentisic acid autoxidation and oxygen radical generation: implications for the etiology of alkaptonuric arthritis.

  1987influential reference
• Protein damage and degradation by oxygen radicals. IV. Degradation of denatured protein.

  1987cited by this paper
• Protein damage and degradation by oxygen radicals. I. general aspects.

  1987cited by this paper
• Protein damage and degradation by oxygen radicals. II. Modification of amino acids.

  1987cited by this paper
• Protein damage and degradation by oxygen radicals. III. Modification of secondary and tertiary structure.

  1987cited by this paper
• Glutathione reductase.

  1985influential reference
• [59] Glutathione reductase

  1985influential reference
• Toxic drug effects associated with oxygen metabolism: Redox cycling and lipid peroxidation

  1981cited by this paper
• A highly sensitive silver stain for detecting proteins and peptides in polyacrylamide gels.

  1979influential reference
• Glutathione peroxidase activity in selenium-deficient rat liver.

  1976influential reference
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper
• Oxidation of homogentisic acid to ochronotic pigment in connective tissue.

  1969cited by this paper
• Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase.

  1967influential reference
• Reaction of quinone of homogentisic acid with biological amines.

  1967cited by this paper
• Studies on ochronosis. II. Studies on benzoquinoneacetic acid, a probale intermediate in the connective tissue pigmentation of alcaptonuria.

  1962cited by this paper
• Studies on ochronosis. I. The distribution of homogentisic acid in guinea pigs.

  1962cited by this paper
• CLINICAL AND PATHOLOGICAL FINDINGS IN OCHRONOSIS

  1960cited by this paper
• The nature of the defect in tyrosine metabolism in alcaptonuria.

  1958cited by this paper
• Inhibition and activation of the oxidation of homogentisic acid.

  1953cited by this paper

• Omics and rare diseases: challenges, applications, and future perspectives

  2025cites this paper
• N6-methyladenosine in 28S rRNA promotes oncogenic mRNA translation and tyrosine catabolism.

  2024cites this paper
• Alkaptonuria: From Molecular Insights to a Dedicated Digital Platform

  2024cites this paper
• Alkaptonuria

  2024cites this paper
• An in vitro cell model for exploring inflammatory and amyloidogenic events in alkaptonuria

  2024cites this paper
• Bacterial quality of urinary tract in patients with alkaptonuria.

  2023cites this paper
• Hydroxyphenylpyruvate dioxygenase is a metabolic immune checkpoint for UTX-deficient colorectal cancer.

  2023cites this paper
• Computational Approaches Integrated in a Digital Ecosystem Platform for a Rare Disease

  2022cites this paper
• Alcaptonurie, ochronose et rhumatisme ochronotique

  2022cites this paper
• Effects of Nitisinone on Oxidative and Inflammatory Markers in Alkaptonuria: Results from SONIA1 and SONIA2 Studies

  2022cites this paper
• Alcaptonuria, ocronosis y artropatía ocronótica

  2022cites this paper
• Association of alkaptonuria and low dose nitisinone therapy with cataract formation in a large cohort of patients

  2022cites this paper
• Homogentisic acid induces autophagy alterations leading to chondroptosis in human chondrocytes: Implications in Alkaptonuria.

  2022cites this paper
• Leveraging proteomics in orphan disease research: pitfalls and potential

  2021cites this paper
• A molecular spectroscopy approach for the investigation of early phase ochronotic pigment development in Alkaptonuria

  2021cites this paper
• Machine learning application for patient stratification and phenotype/genotype investigation in a rare disease

  2021cites this paper
• Machine learning application for development of a data-driven predictive model able to investigate quality of life scores in a rare disease

  2020cites this paper
• Fatal acute haemolysis and methaemoglobinaemia in a man with renal failure and Alkaptonuria – Is nitisinone the solution?

  2020cites this paper
• Cell and tissue models of alkaptonuria

  2020cites this paper
• Homogentisic acid affects human osteoblastic functionality by oxidative stress and alteration of the Wnt/β‐catenin signaling pathway

  2020cites this paper
• Quantification of the flux of tyrosine pathway metabolites during nitisinone treatment of Alkaptonuria

  2019cites this paper
• Evaluation of the serum metabolome of patients with alkaptonuria before and after two years of treatment with nitisinone using LC‐QTOF‐MS

  2019cites this paper
• Ochronotic pigmentation is caused by homogentisic acid and is the key event in alkaptonuria leading to the destructive consequences of the disease—A review

  2019cites this paper
• Interactive alkaptonuria database: investigating clinical data to improve patient care in a rare disease

  2019cites this paper
• Inflammatory and oxidative stress biomarkers in alkaptonuria: data from the DevelopAKUre project.

  2018cites this paper
• Mechanisms of Enhanced Osteoclastogenesis in Alkaptonuria.

  2018cites this paper
• Homogentisic acid induces morphological and mechanical aberration of ochronotic cartilage in alkaptonuria

  2018cites this paper
• A new integrated and interactive tool applicable to inborn errors of metabolism: Application to alkaptonuria

  2018cites this paper
• Homogentisic acid induces aggregation and fibrillation of amyloidogenic proteins.

  2017cites this paper
• Reduced primary cilia length and altered Arl13b expression are associated with deregulated chondrocyte Hedgehog signaling in alkaptonuria

  2017cites this paper
• Cytoskeleton Aberrations in Alkaptonuric Chondrocytes

  2017cites this paper
• Histological and Ultrastructural Characterization of Alkaptonuric Tissues

  2017cites this paper
• Smoothened‐antagonists reverse homogentisic acid‐induced alterations of Hedgehog signaling and primary cilium length in alkaptonuria

  2017cites this paper
• Comparative proteomics in alkaptonuria provides insights into inflammation and oxidative stress.

  2016cites this paper
• Smoothened-antagonists reverse homogentisic acid-induced alterations of Hedgehog signalling and primary cilium length in alkaptonuria † Running head : Hedgehog signalling pathway modulation in alkaptonuria

  2016cites this paper
• Tyrosinase, could it be a missing link in ochronosis in alkaptonuria?

  2016cites this paper
• Old treatments for new insights and strategies: proposed management in adults and children with alkaptonuria

  2015cites this paper
• The Pigment in Alkaptonuria Relationship to Melanin and Other Coloured Substances: A Review of Metabolism, Composition and Chemical Analysis.

  2015cites this paper
• Oxidative stress and mechanisms of ochronosis in alkaptonuria.

  2015influential citation
• Amyloidosis in alkaptonuria

  2015cites this paper
• Homogentisate 1,2 dioxygenase is expressed in brain: implications in alkaptonuria

  2015cites this paper
• Diagnosis of secondary amyloidosis in alkaptonuria

  2014cites this paper
• Amyloidosis, Inflammation, and Oxidative Stress in the Heart of an Alkaptonuric Patient

  2014cites this paper
• Secondary amyloidosis in an alkaptonuric aortic valve☆

  2014cites this paper
• Knee Arthroplasty in Alkaptonuric Arthropathy: A Case Report.

  2013cites this paper
• Redox proteomics gives insights into the role of oxidative stress in alkaptonuria

  2013cites this paper
• Antioxidants inhibit SAA formation and pro-inflammatory cytokine release in a human cell model of alkaptonuria

  2013cites this paper
• NMR-based metabolomics of urine in a mouse model of Alzheimer’s disease: identification of oxidative stress biomarkers

  2013cites this paper